COVID-19 vaccine: FDA pushes back against delaying second dose as US officials, health experts weigh in on debate
The U.S. Food and Drug Administration weighed in on a debate over when the first and second doses of the COVID-19 vaccine should be administered. The FDA said in a statement there is no adequate scientific evidence that supports changing the authorized COVID-19 vaccine schedule or dosing. 'Without appropriate data supporting such changes in vaccine administration, we run a significant risk of placing public health at risk, undermining the historic vaccination efforts to protect the population from COVID-19,' the FDA said
USA Today - January 5, 2021View the full story here: https://www.usatoday.com/story/news/health/2021/01/05/covid-vaccine-fda-us-officials-health-experts-argue-dosing-schedule/4138358001/